Viewing Study NCT03207178

Bugs

Ignite Creation Date: 2025-12-18 @ 9:37 AM

Ignite Modification Date: 2025-12-18 @ 9:37 AM

Study NCT ID: NCT03207178

Status:

Last Update Posted:

First Post:

Is Possible Gene Therapy: False

Has Adverse Events: False

Brief Title: Sequential Infusion of Anti-CD19 and Anti-CD20 CAR-T Cells Against Relapsed and Refractory B-cell Lymphoma

Sponsor:

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Contacts Locations Module Design Module Eligibility Module Outcomes Module References Module